Suchergebnisse - "Bardia, Aditya"

PubPharm (351)

1

Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer : elacestrant as the poster-child

enthalten in: Expert review of anticancer therapy | 2024

von Keenan, J. | Medford, A. | Dai, C. | +3

2

Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

enthalten in: NPJ breast cancer | 2024

von Hurvitz, S. | Bardia, A. | Punie, K. | +8

3

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer : Results From the Phase I TROPION-PanTumor01 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Bardia, A. | Krop, I. | Kogawa, T. | +17

4

Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer

enthalten in: NPJ breast cancer | 2024

von Bar, Y. | Keenan, J. | Niemierko, A. | +5

5

Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan

enthalten in: Cancer treatment reviews | 2024

von Heist, R. | Sands, J. | Bardia, A. | +12

6

TROPION-Breast01 : Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

enthalten in: Future oncology (London, England) | 2024

von Bardia, A. | Jhaveri, K. | Kalinsky, K. | +21

7

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer : Results From the Randomized, Phase II acelERA Breast Cancer Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Martín, M. | Lim, E. | Chavez-MacGregor, M. | +119

8

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

enthalten in: Future oncology (London, England) | 2024

von Rugo, H. | Bardia, A. | Marmé, F. | +4

9

The Right Dose : Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life

enthalten in: JCO oncology practice | 2024

von Loeser, A. | Kim, J. | Peppercorn, J. | +13

10

Ribociclib plus Endocrine Therapy in Early Breast Cancer

enthalten in: The New England journal of medicine | 2024

von Slamon, D. | Lipatov, O. | Nowecki, Z. | +28

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]